secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0001213900-22-041497
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

HSAC2 gets redemption requests for 9.2M shares; RTW Funds buys 1M shares at $10.01 to back Orchestra BioMed deal
--------------------------------------------------------------------------------

- As of July 22, 2022, shareholders requested redemption of 9,237,883 HSAC2 ordinary shares ahead of July 26 vote on extension to Nov 6, 2022.
- RTW Funds (manager affiliate) purchased 1,000,000 HSAC2 shares at $10.01/share from an accredited investor in a private transaction.
- Purchase fulfills RTW's obligations under Forward Purchase Agreement with HSAC2 and Orchestra BioMed, and prevents redemption of those shares to retain trust funds.
- The action increases likelihood that the proposed business combination with Orchestra BioMed ultimately closes.
- The extension proposal would allow additional monthly extensions up to February 6, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000121390022041497/0001213900-22-041497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000121390022041497/ea163262-8k_healthsci2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-041497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer